"just authorizes one if they need it for NASDAQ up listing"
Unfortunately, almost every reverse split uses this justification. Almost every one fails to uplist.
I have no problem admitting that I am dissapointed, again. Getting to uplist levels organically looked possible at one point. Maybe the pandemic has hurt, maybe I overestimated their capabilities. Obviously, it's a gamble with OTC companies. So make your choices and see what happens, right?